Immunohistochemical analysis of human equilibrative nucleoside transporter-1 (hENT1) predicts survival in resected pancreatic cancer patients treated with adjuvant gemcitabine monotherapy (Q95383393)
Jump to navigation
Jump to search
No description defined
Language | Label | Description | Also known as |
---|---|---|---|
English | Immunohistochemical analysis of human equilibrative nucleoside transporter-1 (hENT1) predicts survival in resected pancreatic cancer patients treated with adjuvant gemcitabine monotherapy |
No description defined |
Statements
Immunohistochemical analysis of human equilibrative nucleoside transporter-1 (hENT1) predicts survival in resected pancreatic cancer patients treated with adjuvant gemcitabine monotherapy (English)
Soichiro Morinaga
Yoshiyasu Nakamura
Takuo Watanabe
Hiroshi Mikayama
Hiroshi Tamagawa
Naoto Yamamoto
Manabu Shiozawa
Makoto Akaike
Shinnichi Ohkawa
Yoichi Kameda